Solventum Corporation (SOLV)

Trian Fund Management · 2025-01
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

3
coverage by narrative range · generated from this deck JSON

Slide inventory

25
every slide · same image gating as the playbook
01
Slide 1
This is a press release style summary slide.summarize
02
The slide is text-heavy, structured as a series of bulleted arguments.summarize
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
03
front_matter
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
04
This is a formal activist letter serving as the cover/introductory page of a presentation deck.frame_situation
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
05
This is a text-heavy slide from an activist investor deck (Trian Partners) detailing the investment thesis and subsequent disappointment regarding Solventum.diagnose_problem
Open slide detailBeat · Problem (Identify pain)Loop · Cost Of Inaction
06
The slide argues that management is setting low bars to ensure easy beats, contrasting this with historical 3M performance and industry-wide spin-off margin expcompare_peers
Open slide detailBeat · Agitate (Make it worse)Loop · Cost Of Inaction
07
The slide combines a quantitative precedent table with qualitative strategic recommendations for the company.cite_precedent
Open slide detailBeat · Agitate (Make it worse)Loop · Cost Of Inaction
08
This is a text-heavy slide acting as a formal closing letter from an activist investor.closing_ask
Open slide detailBeat · Agitate (Make it worse)Loop · Cost Of Inaction
09
front_matter
Open slide detailBeat · Agitate (Make it worse)Loop · Cost Of Inaction
10
The slide uses a table to summarize the 2023 business mix across four segments: MedSurg, Health Info Systems, Dental Solutions, and Purification & Filtration.summarize
Open slide detailBeat · Agitate (Make it worse)Loop · Cost Of Inaction
11
The chart includes a table summarizing average organic growth over various time horizons (3, 5, 10, 20 years).compare_peers
Open slide detailBeat · Agitate (Make it worse)Loop · Cost Of Inaction
12
The slide uses a 2x2 grid layout to present four distinct analyst perspectives.cite_precedent
Open slide detailBeat · Agitate (Make it worse)Loop · Cost Of Inaction
13
The slide uses a table to contrast analyst expectations at the time of the spin-off announcement against current market pricing to argue for undervaluation.preempt_rebuttal
Open slide detailBeat · Agitate (Make it worse)Loop · Cost Of Inaction
14
The chart highlights the valuation gap between Solventum and its peers, suggesting the market is underestimating its earnings potential.compare_peers
Open slide detailBeat · Agitate (Make it worse)Loop · Cost Of Inaction
15
The slide uses a before-after framing to argue that the spin-off has resulted in performance degradation rather than the expected improvement.expose_gap
Open slide detailBeat · Solution (Provide relief)Loop · Cost Of Inaction
16
The chart uses a waterfall-style ordering (descending) to emphasize the current low performance.diagnose_problem
Open slide detailBeat · Solution (Provide relief)Loop · Cost Of Inaction
17
The slide highlights a discrepancy between analyst expectations and historical performance to argue for better potential.expose_contradiction
Open slide detailBeat · Solution (Provide relief)Loop · Cost Of Inaction
18
The chart highlights Solventum's outlier performance in margin deterioration compared to historical precedents.compare_peers
Open slide detailBeat · Solution (Provide relief)Loop · Cost Of Inaction
19
The slide uses a 'Precedent Spin Analysis' to justify a 27% margin target for Solventum.compare_peers
Open slide detailBeat · Solution (Provide relief)Loop · Cost Of Inaction
20
The slide uses a bar chart to compare historical Solventum allocations against peer benchmarks, arguing that Solventum was over-allocated costs by 3M.compare_peers
Open slide detailBeat · Solution (Provide relief)Loop · Cost Of Inaction
21
Uses case studies of GE and DuPont/Axalta to argue for corporate spin-offs.preempt_rebuttal
Open slide detailBeat · Solution (Provide relief)Loop · Cost Of Inaction
22
The slide uses a before-after structure to highlight the deterioration of Solventum's growth relative to peers.diagnose_problem
Open slide detailBeat · Solution (Provide relief)Loop · Cost Of Inaction
23
Includes a 'Restoring Performance' WholeCo Valuation Analysis table with supporting commentary.show_valuation_bridge
Open slide detailBeat · Solution (Provide relief)Loop · Cost Of Inaction